FDA approves first hypoxia-inducible factor prolyl hydroxylase inhibitor

被引：0
|
作者：
Asher Mullard
机构：
来源：
Nature Reviews Drug Discovery | 2023年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：173 / 173
相关论文
共 50 条
  • [31] Roxadustat, an hypoxia-inducible factor-prolyl hydroxylase inhibitor induce sickle cell crisis: A case report
    Chabannes, Melchior
    Vagnet, Antonin
    Benjemia, Lise
    Seibel, Jean
    Tristant, Maxime
    Rabier, Marie-Blanche
    Crepin, Thomas
    Ducloux, Didier
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [32] Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects
    Akizawa, Tadao
    Tsubakihara, Yoshiharu
    Nangaku, Masaomi
    Endo, Yukihiro
    Nakajima, Hiromu
    Kohno, Tomoko
    Imai, Yukiko
    Kawase, Natsumi
    Hara, Katsutoshi
    Lepore, John
    Cobitz, Alexander
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2017, 45 (02) : 127 - 135
  • [33] Daprodustat Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor Treatment of anemia associated with chronic kidney disease
    Gras, J.
    [J]. DRUGS OF THE FUTURE, 2017, 42 (06) : 327 - 333
  • [34] Hypoxia-inducible factor-prolyl hydroxylase inhibitor ameliorates myopathy in a mouse model of chronic kidney disease
    Qian, Fang-Yuan
    Li, Zuo-Lin
    Guo, Yu-Dong
    Gao, Han-Chao
    Gu, Li-Hua
    Le, Kai
    Xie, Chun-Ming
    Wang, Bin
    Zhang, Zhi-Jun
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 317 (05) : F1265 - F1273
  • [35] Exacerbation of Diabetic Retinopathy following Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Administration: A Case Report
    Ariyoshi, Nobuaki
    Higashijima, Fumiaki
    Wakuta, Makiko
    Ogata, Tadahiko
    Ohta, Manami
    Kimura, Kazuhiro
    [J]. CASE REPORTS IN OPHTHALMOLOGY, 2024, 15 (01): : 256 - 264
  • [36] Discovery of DS-1093a: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia
    Tanaka, Naoki
    Fukuda, Takeshi
    Takano, Rieko
    Sasaki, Koji
    Tsuji, Takashi
    Goto, Riki
    Kuribayashi, Takeshi
    Yamaguchi, Kyoji
    Niitsu, Yoichi
    Ishii, Ken
    Hashimoto, Masami
    Takahashi, Shinichi
    Obayashi, Hisakuni
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 111
  • [37] VADADUSTAT Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor Treatment of anemia secondary to chronic kidney disease
    Cole, P.
    [J]. DRUGS OF THE FUTURE, 2016, 41 (10) : 601 - 606
  • [38] Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
    Moslehi, Javid
    Minamishima, Yoji Andrew
    Shi, Jianru
    Neuberg, Donna
    Charytan, David M.
    Padera, Robert F.
    Signoretti, Sabina
    Liao, Ronglih
    Kaelin, William G., Jr.
    [J]. CIRCULATION, 2010, 122 (10) : 1004 - U108
  • [39] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Post Kidney Transplant Anemia
    Ogata, Masatomo
    Miyauchi, Takamasa
    Murata, Marie
    Terashita, Maho
    Osako, Kiyomi
    Shinoda, Kazunobu
    Shibagaki, Yugo
    Yazawa, Masahiko
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 552 - 552
  • [40] Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
    Ivan, M
    Haberberger, T
    Gervasi, DC
    Michelson, KS
    Günzler, V
    Kondo, K
    Yang, HF
    Sorokina, I
    Conaway, RC
    Conaway, JW
    Kaelin, WG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) : 13459 - 13464
12345